BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 90055)

  • 1. Concentration of dihydrotestosterone and 3 alpha-androstanediol in naturally occurring and androgen-induced prostatic hyperplasia in the dog.
    Moore RJ; Gazak JM; Quebbeman JF; Wilson JD
    J Clin Invest; 1979 Oct; 64(4):1003-10. PubMed ID: 90055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J; Hicks LL; Walsh PC
    J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign prostatic hyperplasia: etiological considerations.
    Walsh PC
    Prog Clin Biol Res; 1976; 6():1-8. PubMed ID: 66685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
    Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor content of nafoxidine treated experimentally induced canine prostatic hyperplasia.
    Trachtenberg J
    Clin Invest Med; 1985; 8(1):29-34. PubMed ID: 2580656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol.
    Moore RJ; Gazak JM; Wilson JD
    J Clin Invest; 1979 Mar; 63(3):351-7. PubMed ID: 219036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
    Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
    J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The induction of prostatic hypertrophy in the dog with androstanediol.
    Walsh PC; Wilson JD
    J Clin Invest; 1976 Apr; 57(4):1093-7. PubMed ID: 59740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog.
    Gloyna RE; Siiteri PK; Wilson JD
    J Clin Invest; 1970 Sep; 49(9):1746-53. PubMed ID: 4194769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Light-microscopic stereologic analysis of spontaneous and steroid-induced canine prostatic hyperplasia.
    Bartsch G; Bruengger A; de Klerk DP; Coffey DS; Rohr HP
    J Urol; 1987 Mar; 137(3):552-8. PubMed ID: 2434668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible mechanism of induction of benign prostatic hyperplasia by estradiol and dihydrotestosterone in dogs.
    Winter ML; Liehr JG
    Toxicol Appl Pharmacol; 1996 Feb; 136(2):211-9. PubMed ID: 8619228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydrotestosterone and 3 alpha-androstanediol dynamics in the normal, involuted, and hyperplastic canine prostate.
    McKercher G; Chevalier S; Roberts KD; Bleau G; Chapdelaine A
    Steroids; 1986; 48(1-2):55-72. PubMed ID: 2444022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of 3 alpha-androstanediol-induced growth of the dog prostate.
    Jacobi GH; Moore RJ; Wilson JD
    Endocrinology; 1978 Jun; 102(6):1748-58. PubMed ID: 744048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is the prostatic adenoma of hormonal origin].
    Bercovici JP; Morfin R; Charles JF
    Nouv Presse Med; 1975 Feb; 4(7):475-8. PubMed ID: 48234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supranormal nuclear content of 5 alpha-dihydrotestosterone in benign hyperplastic prostate of humans.
    Meikle AW; Collier ES; Middleton RG; Fang SM
    J Clin Endocrinol Metab; 1980 Oct; 51(4):945-7. PubMed ID: 6158523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen concentrations and their receptors in the periurethral region are higher than those of the subcapsular zone in benign prostatic hyperplasia (BPH).
    Monti S; Di Silverio F; Toscano V; Martini C; Lanzara S; Varasano PA; Sciarra F
    J Androl; 1998; 19(4):428-33. PubMed ID: 9733145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy.
    Lloyd JW; Thomas JA; Mawhinney MG
    Invest Urol; 1975 Nov; 13(3):220-22. PubMed ID: 53217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis of prostatic hyperplasia in normal and adenomatous glands of men and dogs: 3-alpha reduction of dihydrotestesterone].
    Jacob GH
    Endokrinologie; 1977 Oct; 70(2):158-68. PubMed ID: 73458
    [No Abstract]   [Full Text] [Related]  

  • 20. 3alpha-Reduction of dihydrotestosterone in human normal and hypertrophic prostatic tissues.
    Shida K; Shimazaki J; Ito Y; Yamanaka H; Nagai-Yuasa H
    Invest Urol; 1975 Nov; 13(3):241-5. PubMed ID: 53218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.